ReproCELL appeared to be the Corporate Investor, which was created in 2003. The fund was located in Asia if to be more exact in Japan. The leading representative office of defined Corporate Investor is situated in the Yokohama.
The usual things for fund are deals in the range of 5 - 10 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The high activity for fund was in 2019.
Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Business Intelligence, Health Care. Among the most popular portfolio startups of the fund, we may highlight Symic Biomedical.
The typical case for the fund is to invest in rounds with 5 participants. Despite the ReproCELL, startups are often financed by Zenyaku Kogyo, Nissei Capital, Nippon Venture Capital. The meaningful sponsors for the fund in investment in the same round are Zenyaku Kogyo, Shinsei Bank, Keio Innovation Initiative. In the next rounds fund is usually obtained by Tohoku University Venture Partners.
Related Funds
Fund Name | Location |
Apollo Investment Corporation | New York, New York, United States |
Bonneville Power Administration | Oregon, Portland, United States |
Daimler | Baden-Wurttemberg, Germany, Stuttgart |
Hivers and Strivers | - |
Licheng Fuyi Touzi | Baoshan, China, Shanghai |
LOI Labs | British Columbia, Canada, Vancouver |
Maroc Numeric Fund | Casablanca, Grand Casablanca, Morocco |
Maryland Health Care Product Development | Maryland, Rockville, United States |
MegaDelta Capital | - |
Nest Collective Foundation | - |
NSV Wolf Capital | California, Menlo Park, United States |
PacRim Venture Partners | California, Menlo Park, United States |
Positive Ventures | Brazil, São Paulo, São Paulo |
Relentless Pursuit Partners | British Columbia, Canada, Vancouver |
Sauzalito Ventures | California, Sausalito, United States |
Tasly Holding Group | China, Guangdong, Tianjin |
TRANSSION | China, Guangdong, Shenzhen |
Tronfund | China, Huangpu, Shanghai |
UTIMCO | Austin, Texas, United States |
Zhuoyuan Capital | China, Guangdong, Shenzhen |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Symic Biomedical | $11M | 25 Apr 2019 | California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Symic Biomedical | $11M | 25 Apr 2019 | California, United States |